About ssy group ltd - LJUIF
SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. It operates through the following segments: Intravenous Infusion Solution and Others and Medical Materials. The company was founded on September 28, 2004 and is headquartered in Hong Kong.
LJUIF At a Glance
SSY Group Ltd.
Rooms 4902-03, 49/F
Hong Kong,
| Phone | 852-2688-0869 | Revenue | 534.31M | |
| Industry | Pharmaceuticals: Major | Net Income | 60.37M | |
| Sector | Health Technology | Employees | 5,500 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
LJUIF Valuation
| P/E Current | 18.052 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 17.65 |
| Price to Sales Ratio | 1.996 |
| Price to Book Ratio | 1.144 |
| Price to Cash Flow Ratio | 13.07 |
| Enterprise Value to EBITDA | 12.232 |
| Enterprise Value to Sales | 2.601 |
| Total Debt to Enterprise Value | 0.371 |
LJUIF Efficiency
| Revenue/Employee | 97,146.408 |
| Income Per Employee | 10,976.132 |
| Receivables Turnover | 2.446 |
| Total Asset Turnover | 0.327 |
LJUIF Liquidity
| Current Ratio | 1.892 |
| Quick Ratio | 1.434 |
| Cash Ratio | 0.694 |
LJUIF Profitability
| Gross Margin | 38.924 |
| Operating Margin | 10.38 |
| Pretax Margin | 13.533 |
| Net Margin | 11.299 |
| Return on Assets | 3.694 |
| Return on Equity | 6.465 |
| Return on Total Capital | 4.152 |
| Return on Invested Capital | 4.754 |
LJUIF Capital Structure
| Total Debt to Total Equity | 54.988 |
| Total Debt to Total Capital | 35.479 |
| Total Debt to Total Assets | 31.332 |
| Long-Term Debt to Equity | 30.752 |
| Long-Term Debt to Total Capital | 19.842 |